SETD8 inhibition targets cancer cells with increased rates of ribosome biogenesis
Matilde Murga, Gema López-Pernas, Robert Soliva, Elena Fueyo‐Marcos, Corina Amor, Ignacio Faustino, Marina Serna, Alicia G. Serrano, Lucía Díaz, Sonia Martı́nez, Carmen Blanco‐Aparicio, Marta Elena Antón, Brinton A. Seashore-Ludlow, Joaquı́n Pastor, Rozbeh Jafari, , Óscar Fernández-Capetillo
This study identifies novel SETD8 inhibitors and shows their toxicity correlates with ribosome biogenesis regulators, suggesting a biomarker for targeted cancer therapy.
Cell Death and Disease · Sep 28, 2024Peer-reviewedCancer Biology